LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5.
Published May 7, 2014 · Recall initiated: March 10, 2014
Summary
FDA records drug Class II recall D-1289-2014, published May 7, 2014 and initiated March 10, 2014. Recalling firm: AbbVie Inc; Status: Terminated; Reported quantity: 12 kits; Lot: Lot #:1013566, Exp 12/08/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
What to do
Voluntary: Firm initiated · Letter
Get an email if LUPRON DEPOT-PED has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LUPRON DEPOT-PED
- Manufacturer
- AbbVie Inc
- Distributor
- Nationwide and Puerto Rico
- UPC
- 300743779035
- Lot
- Lot #:1013566, Exp 12/08/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDALupron Depot (leuprolide acetate for depot suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDAMaximum Strength/Non-Drowsy Tussin DM Adult Maximum Strength, Cough Cold, Dextromethorphan HBr, USP, 10 mgMay 7, 2014
- FDACetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat,May 7, 2014
Questions about this recall
Was LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5. recalled?
Yes. FDA published recall D-1289-2014 on May 7, 2014. Reported hazard: Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LUPRON DEPOT-PED. UPC: 300743779035.